WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 4 fonti

Experts hail ‘new age of diabetes treatment’ as drug approved on NHS

Teplizumab is approved for children aged eight and over

Raccontata dadailymail.comindependent.co.uktheguardian.comnews.yale.edu

Confronto fonti

4 prospettive sulla stessa storia
AI · summaries
independent.co.ukStai leggendo15 g fa

Experts hail ‘new age of diabetes treatment’ as drug approved on NHS

Teplizumab is approved for children aged eight and over

originale
dailymail.com15 g fa

Drug that delays type 1 diabetes by up to three years approved by NHS

The National Institute for Health and Care Excellence (Nice) has approved teplizumab, with Diabetes UK saying it 'marks the start of a new age of treatment'.

Leggi questa versione → originale
theguardian.com15 g fa

Drug that delays onset of type 1 diabetes approved in England and Wales

Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ‘incredible moment’

Leggi questa versione → originale
news.yale.edu13 g fa

‘Paradigm-shifting’ treatment for pediatric diabetes cleared by FDA

Yale’s Kevan Herold was the senior investigator on a clinical trial which showed that the drug teplizumab — recently approved for pediatric patients with Stage 3 Type 1 diabetes — delays the progression of the disease.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 23 giugno 2026·dailymail.com

    Drug that delays type 1 diabetes by up to three years approved by NHS

    The National Institute for Health and Care Excellence (Nice) has approved teplizumab, with Diabetes UK saying it 'marks the start of a new age of treatment'.

  2. martedì 23 giugno 2026·independent.co.uk

    Experts hail ‘new age of diabetes treatment’ as drug approved on NHS

    Teplizumab is approved for children aged eight and over

  3. martedì 23 giugno 2026·independent.co.uk

    NHS approves breakthrough drug that can delay type 1 diabetes for years

    Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

  4. martedì 23 giugno 2026·theguardian.com

    Drug that delays onset of type 1 diabetes approved in England and Wales

    Availability of teplizumab on the NHS – which postpones early stages of disease for up to three years – described as an ‘incredible moment’

  5. giovedì 25 giugno 2026·news.yale.edu

    ‘Paradigm-shifting’ treatment for pediatric diabetes cleared by FDA

    Yale’s Kevan Herold was the senior investigator on a clinical trial which showed that the drug teplizumab — recently approved for pediatric patients with Stage 3 Type 1 diabetes —…